000 01580 a2200337 4500
005 20250516005348.0
264 0 _c20110406
008 201104s 0 0 eng d
022 _a1538-7755
024 7 _a10.1158/1055-9965.EPI-10-0580
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Zhen
245 0 0 _aThe road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.
_h[electronic resource]
260 _bCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
_cDec 2010
300 _a2995-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBiological Assay
_xmethods
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xdiagnosis
650 0 4 _aProteomics
_xmethods
650 0 4 _aRisk Factors
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
650 0 4 _aValidation Studies as Topic
700 1 _aChan, Daniel W
773 0 _tCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
_gvol. 19
_gno. 12
_gp. 2995-9
856 4 0 _uhttps://doi.org/10.1158/1055-9965.EPI-10-0580
_zAvailable from publisher's website
999 _c20265021
_d20265021